Skip to main content

Quotient Ltd

QTNTDelisted Dec 22, 2022
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001596946

Quotient Ltd was delisted on Dec 22, 2022; its insiders filed their last Form 4 on Feb 2, 2023; 51 institutions reported holding it in 13F filings for Q3 2022, worth $10.1M in total; no superinvestor held it.

Holders of 5% or more of QTNT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Quotient Ltd, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Quotient Ltd on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Quotient Ltd, newest first.

Schedule 13D and 13G filings on QTNT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 11, 2021Pura Vida Investments, LLC13GOld format–New–SEC
Feb 16, 2021Perceptive Advisors LLC13G/AOld format–––SEC
Feb 16, 2021Polar Capital Holdings Plc13G/AOld format–––SEC
Feb 12, 202110:45 AM ETAmeriprise Financial Inc13GOld format–New–SEC
Feb 12, 2021Credit Suisse AG13GOld format–New–SEC
Feb 10, 20213:04 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 9, 2021Highbridge Capital Management LLC13G/AOld format–––SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Quotient Ltd shares.

No Form 144 notices for Quotient Ltd are on file.